Skip to main content
. 2012 Aug 15;2012(8):CD008465. doi: 10.1002/14651858.CD008465.pub2

Brown 2006.

Study characteristics
Methods Study design: RCT
Number randomized: 115; 57 to the exercise group and 58 to the control group
Study start and stop dates: not reported
Length of intervention: 4 weeks
Length of follow‐up: 4, 7, and 27 weeks after baseline
Participants Type cancer, n (%): various
  • exercise group: brain, 6 (12.7%); head and neck, 7 (14.3%); lung, 9 (18.4%); ovarian, 1 (2.0%); gastrointestinal, 18 (36.7%); other, 8 (16.3%)

  • control group: brain, 6 (11.1%); head and neck, 11 (20.4%); lung, 6 (11.1%); ovarian, 0 (0.0%); gastrointestinal, 21 (38.9%); other, 10 (18.5%)


Time since cancer diagnosis: not reported
Time in active treatment: not reported
Inclusion criteria:
  • adults

  • scheduled to undergo radiation therapy for at least 2 weeks

  • cancer diagnosis within the past 12 months

  • expected survival of at least 6 months, but a 5‐year survival probability of no more than 50%


Eligibility criteria related to interest or ability, or both, to exercise:
  • none, but participants were screened preceding the exercise intervention to assure ability to participate


Exclusion criteria:
  • MMSE score < 20

  • ECOG performance score of ≥ 3

  • active alcohol or substance dependence (except nicotine)

  • active thought disorder

  • suicidal plans

  • participation in a psychosocial research trial


Gender, n (%):
  • exercise group: male, 29 (59.2%); female, 20 (40.8%)

  • control group: male, 37 (58.5%); female, 17 (31.5%)


Current age, n (%):
  • exercise group: < 50 years, 7 (14.3%); ≥ 50 years, 42 (85.7%)

  • control group: < 50 years, 12 (22.2%); ≥ 50 years, 42 (77.8%)


Age at cancer diagnosis: not reported
Ethnicity/race: all patients were white or of unknown ethnicity
Education level: not reported
SES: not reported
Employment status, currently employed, n (%):
  • exercise group: 10 (35.7%)

  • control group: 29 (53.7%)


Comorbidities: not reported
Past exercise history: not reported
On hormone therapy: not reported
Interventions 57 participants assigned to the exercise intervention, including:
  • a structured multidisciplinary intervention focused on specific strategies designed to improve participants' overall QoL. Sessions included 20 minutes of exercises, including:

    • seated active ROM exercises of upper and lower extremities, progressing to resistive exercises with an elastic band

    • stretching exercises

    • functional lower extremity exercises (e.g. marching in place) stressing increasing endurance

  • Educational sessions coinciding with exercise sessions


Type exercise (aerobic/anaerobic): aerobic and anaerobic
Intensity of the experimental exercise intervention: not reported
Frequency: twice per week
Duration of individual sessions: 90 minutes
Duration of exercise program: 4 weeks
Total number of exercise sessions: 8 sessions
Format: group
Facility: facility
Professionally led by a physical therapist
Adherence: 78% of participants attended all sessions, 92% attended all but 1 session. No subject missed more than 2 sessions
58 participants assigned to control group, including:
  • usual care


Contamination of control group: not reported
Outcomes Primary outcome:
  • global HRQoL, but how assessed was not reported


Other outcomes included:
  • fatigue, assessed using:

    • Linear Analogue Self Assessment fatigue

    • Profile of Moods State fatigue‐inertia and vigor‐activity subscales

    • Speilberger's STAI fatigue question

    • Symptom Distress Scale fatigue question


Outcomes were measured at baseline, 4 weeks, 7 weeks, and 27 weeks:
  • exercise group: n = 55 at baseline, n = 46 at 4 weeks, number of participants completing longer follow‐up visits not reported

  • control group: n = 57 at baseline, n = 54 at 4 weeks, number of participants completing longer follow‐up visits not reported


Subgroup analysis: none reported
Adverse events: not reported
Notes Country: US
Funding: Linse Bock Foundation, Saint Mary's Hospital Sponsorship Board
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk The generation of the random sequence was not described
Allocation concealment (selection bias) Unclear risk Whether the treatment assignment was concealed from study personnel and participants was not described
Blinding of participants and personnel (performance bias)
All outcomes High risk Owing to the nature of the intervention, it was not possible to conceal allocation to the intervention from the participants
Blinding of outcome assessment (detection bias)
All outcomes High risk Allocation to the intervention was not concealed from the study personnel
Incomplete outcome data (attrition bias)
All outcomes High risk The number of participants who withdrew from the study was not reported beyond the 4‐week period. An ITT analysis was not completed
Selective reporting (reporting bias) High risk The authors describe some QoL measures in the methods for which no results are presented
Other bias Low risk The trial appears to be free of other problems that could put it at a high risk of bias